Johanson Financial Advisors’s Vir Biotechnology VIR Stock Holding History

Johanson Financial Advisors’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$213K	Hold	5,092	–	–	0.07%	123
2021 Q3	$222K	Buy	+5,092	New	+$220K	0.08%	111
2021 Q2	–	Sell	-5,092	Closed	-$232K	–	122
2021 Q1	$232K	Sell	5,092 -14,000	-73%	-$755K	0.08%	103
2020 Q4	$511K	Sell	19,092 -2,000	-9%	-$65K	0.21%	77
2020 Q3	$825K	Buy	+21,092	New	+$908K	0.37%	56

Other funds holding VIR

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return

Johanson Financial Advisors's VIR Position: Q4 2021 in Review

Johanson Financial Advisors held its Vir Biotechnology (VIR) position steady in Q4 2021 at 5,092 shares worth $213K. The position accounts for 0.07% of the portfolio, ranked #123.

Johanson Financial Advisors first reported a position in VIR in Q3 2020 and has held it in 5 quarters since. The position peaked at $825K in Q3 2020. 210 funds tracked by Wall St. Rank hold VIR as of Q4 2021.

Johanson Financial Advisors held 5,092 shares of Vir Biotechnology worth $213K as of Q4 2021.
Johanson Financial Advisors left its Vir Biotechnology share count unchanged in Q4 2021.
Vir Biotechnology made up 0.07% of Johanson Financial Advisors's portfolio in Q4 2021, its #123 holding.
Johanson Financial Advisors first reported a position in Vir Biotechnology in Q3 2020 and has held it in 5 quarters since.
Johanson Financial Advisors's Vir Biotechnology position peaked at $825K in Q3 2020.
210 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2021.

Based on Johanson Financial Advisors's 13F filing for Q4 2021, filed 19 Jan 2022.